The tier that is not named
Two of the three tiers are labelled compounded and the third is labelled Original. That contrast is the seller's own, and in this market original against compounded ordinarily means the approved, manufactured product against a pharmacy preparation. The figure is consistent with that reading: it sits in the same range as the brand-name cash prices other sellers on this roster publish.
But the page never says it. There is no manufacturer, no product name, no molecule and no strength. We have recorded it as a brand-route figure, with the omission written into the row's own qualifier, because a reader comparing brand prices across this roster should be able to see it and should also be able to see that this seller will not name what it is selling.
Fifty-three of the one hundred and fifty-eight sellers here offer a brand route of some kind. Most of the ones that publish a figure also say which product it buys.
The two tiers it does explain
A compounded weekly injection and a compounded daily dissolvable tablet are priced separately, and the tablet costs more. Twenty-seven of the one hundred and fifty-eight sellers here price an oral route at all, and pricing it as its own tier rather than as an upsell inside the injection plan is the clearer way to do it.
The molecule is named in the copy around the compounded lanes, so the ambiguity is confined to the third tier.
What is stated and what is not
The page states no hidden fees, no monthly membership and cancel anytime, in three separate places. Fifty-five of the one hundred and fifty-eight sellers here state that no membership fee applies, and repeating it in three places is a stronger form of the claim than one line.
The operating company and its address sit in the footer of the priced page and of the policies page. No compounding pharmacy is named beyond a phrase describing a certified pharmacy; one hundred and twenty-six of the one hundred and fifty-eight sellers here name none. No individual clinician is named, and no service area is published.
A site-wide discount banner rode the priced page on the day it was read, offering a stated amount off all weight-loss plans.
FeelGood's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $149/mostarting at, per month, for the compounded injection tier | September 2026source |
| Semaglutide (compounded-oral) | $249/mostarting at, per month, for the compounded tablet tier | September 2026source |
| Glp-1 (brand) | $1,999/mostarting at, per month, for a tier the seller labels Original Injections against its own Compounded Injections tier; no manufacturer, brand or molecule is named beside it, and the card adds that quantities are limited and availability is subject to change | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 158 providers reviewed here are paid partners today; the other 154 are not. See how this works.
See FeelGood's current price →Good fit if
- Readers who want to see what a seller charges for a non-compounded injection, and to notice that it does not say which one.
- Buyers who want a daily tablet priced as its own tier rather than as an add-on.
- People who want the no-membership position stated in plain words.
Look elsewhere if
- Anyone considering the expensive tier. It is priced and unidentified.
- Readers who want the compounding pharmacy or a clinician named.
- Buyers who need a service-area list.
- People who want a price that is not sitting under a discount banner.
How this review was verified
- Re-read the weight-loss page and the policies page on 6 September 2026, comparing the requested path to the effective path and running a nonsense path against the host in the same run.
- Recorded the unidentified tier as a brand-route figure and wrote the omission into the price row's own qualifier rather than inferring a product name for it.
- Confirmed that the same three tier figures render on the policies page as well as the priced page, so they are the site's own standing numbers rather than a single banner.
- Read the no-membership statement from three separate occurrences on the priced page.
- Screened the operating entity and the brand name against FDA's live warning-letter record with a known letter as a positive control and a nonsense string as a negative control in the same pass. Neither returned a letter. Untitled letters are published separately and were not searched.